NEW YORK (GenomeWeb News) – Ambry Genetics has been certified to provide Agilent Technologies' SureSelect Target Enrichment System services for next-generation sequencing projects, Agilent said today.

Ambry, which is located in Aliso Viejo, Calif., received the Certified Service Provider status after demonstrating proficiency using the system with the Illumina Genome Analyzer, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.